Pharmaceutical Phenylbutazone API oral powder for horses cas 50-33-9
A non-steroidal anti-inflammatory compound. An inhibitor of cyclooxygenase that is also a substrate for peroxidation by cyclooxygenase. Antipyretic analgesics,For fever, headache, arthralgia, neuralgia, dysmenorrhea and active rheumatism, etc.Amidopyrine genus pyrazole ketones non steroid anti-inflammatory drugs, has strong antipyretic analgesic, anti-inflammatory and anti rheumatism.
Mainly for the treatment of rheumatoid arthritis, rheumatoid arthritis, ankylosing spondylitis. The large dose of this drug can reduce the reabsorption of urate in the renal tubules and promote the excretion of urate, so it can be used to treat acute gout
1. Common adverse reactions include nausea, vomiting, gastrointestinal discomfort, sodium retention, edema, and rash;
2. Can also cause diarrhea, dizziness, headache, long-term high-dose gastrointestinal ulcers and gastrointestinal bleeding;
3. Occasionally causes hepatitis, jaundice, nephritis, hematuria, exfoliative dermatitis, erythema multiforme, goiter, granulocyte and thrombocytopenia;
4. Medication should be checked more than one week after taking the drug. If fever, sore throat, rash, jaundice and tarry stools should be discontinued immediately.
Those who are allergic to aspirin have a history of ulcers, edema, hypertension, psychosis, epilepsy, bronchial asthma, heart disease, and liver and kidney dysfunction.
|PRODUCT NAME ||Phenylbutazone|
|CAS no.||50-33-9||Outer packing||25KG/foil bag|
|Storage||Store in a well-closed container away from moisture|
|Items of analysis||Specification||Results|
|Description||White or almost white crystalline powder||Complies|
|Identification||IR Absorption||Positive reaction|
| ||UV Absorption||Positive reaction|
|Appearance of solution||Clear||Complies|
|Acidity or Alkalinity||Complies||Complies|
|Loss on drying||≤0.2%%||0.08%|
|Residue on ignition||≤0.1%||0.06%|
|Organic Volatile Impurities||Complies||Complies|
|Conclusion||Conforms to EP8.0&USP37 Specification|